Market Snapshot: Global Insulin Pumps Market Eyes Nearly 10% Growth By 2022
The worldwide insulin pumps market is expected to reach more than $4.5bn by 2022, a CAGR of nearly 10%. This market is largely driven by the rising prevalence of diabetes and the need to control spiraling health-care costs associated with diabetes-related complications. While Medtronic's MiniMed 670G dominates the market, Informa's MedDeviceTracker expects Medtronic will see rising competition from innovative start-ups.
You may also be interested in...
Interoperability and the rising use of continuous glucose monitoring is fueling competition among diabetes device-makers and dominated the conversation at the recent annual ADA meeting.
At this year's American Diabetes Association (ADA) meeting in San Francisco, medtech giant Medtronic made several key announcements including a collaboration with Tidepool Loop, the start of a new patient trial to develop its next-generation hybrid closed-loop system and another trial to improve its sensor technology. Medtech Insight met up with Hiten Chawla, Medtronic's VP of global marketing for its diabetes business, to learn more about these plans.
Grail announced results from an initial validation study that showed its early-detection blood test could identify 12 of the deadliest cancers with a low rate of false-positive results.